サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1468567

COPD・喘息用装置市場レポート：製品、適応症、流通チャネル、地域別、2024～2032年

COPD and Asthma Devices Market Report by Product (Inhalers, Nebulizers), Indication (Asthma, COPD), Distribution Channel (Retail Pharmacies, Hospitals, Online Pharmacies), and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 137 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
COPD・喘息用装置市場レポート：製品、適応症、流通チャネル、地域別、2024～2032年
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 137 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

COPD・喘息用装置の世界市場規模は、2023年に457億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに695億米ドルに達し、2024～2032年の間に4.6%の成長率（CAGR）を示すと予測しています。

慢性閉塞性肺疾患（COPD）は、肺からの気流障害を引き起こす炎症性疾患です。その初期症状には、息切れ、喘鳴、胸部圧迫感、粘液を伴うか伴わない慢性的な咳、頻繁な風邪、喉の痛みなどがあります。一方、気管支喘息とも呼ばれる喘息は、肺の気道に影響を及ぼす呼吸器疾患です。その症状は、息切れ、胸の圧迫感、睡眠障害、咳や喘鳴発作などです。これらの呼吸器疾患は、吸入薬の投与を助けるさまざまな装置を用いて治療されます。COPD・喘息用装置は、肺ドラッグデリバリーデバイスとしても知られ、呼吸器疾患の恒久的治療または救援療法として使用されます。その結果、世界中で絶大な支持を得ています。

COPD・喘息用装置の市場動向：

慢性呼吸器疾患に罹患しやすい世界の高齢者人口の増加は、市場にプラスの影響を与える主要要因の1つです。また、たばこの喫煙増加による呼吸器疾患の増加が、COPD・喘息用装置の売上を増加させています。これとは別に、医療への支出の増加と医療産業における継続的な自動化が市場成長に寄与しています。先進医療ソリューションの普及は、世界中のメーカーに有利な成長機会を提供しています。現在、医療開業医や肺疾患専門医は、その迅速かつ効果的な結果を理由に、薬剤と装置の組み合わせを好んでいます。さらに、化学工業の拡大が環境汚染レベルの上昇と呼吸器系の問題を引き起こしており、これが市場を牽引しています。さらに、携帯型ドラッグデリバリーデバイスの導入が市場の成長を促進しています。

本レポートで扱う主要質問

  • 2023年のCOPD・喘息用装置の世界市場規模は？
  • 2024～2032年のCOPD・喘息用装置の世界市場の予想成長率は？
  • COPD・喘息用装置の世界市場を牽引する主要因は？
  • COPD・喘息用装置の世界市場に対するCOVID-19の影響は？
  • COPD・喘息用装置の世界市場の製品別区分は？
  • COPD・喘息用装置の世界市場の適応症別区分は？
  • COPD・喘息用装置の世界市場の流通チャネル別区分は？
  • COPD・喘息用装置の世界市場における主要地域は？
  • COPD・喘息用装置の世界市場における主要参入企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 COPD・喘息用装置の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 吸入器
    • 市場動向
    • 主要セグメント
      • 薬剤粉末吸入器（DPI）
      • 定量吸入器（MDI）
      • ソフトミスト吸入器
    • 市場予測
  • ネブライザー
    • 市場動向
    • 主要セグメント
      • コンプレッサー式ネブライザー
      • 超音波式ネブライザー
      • メッシュ式ネブライザー
    • 市場予測

第7章 市場内訳：適応症別

  • 喘息
  • COPD

第8章 市場内訳：流通チャネル別

  • 小売薬局
  • 病院
  • オンライン薬局

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Adherium Limited
    • Aristopharma Ltd.
    • AstraZeneca PLC
    • Baxter International Inc.
    • Boehringer Ingelheim International GmbH
    • Cohero Health Inc.
    • Koninklijke Philips N.V.
    • Omron Corporation
    • Pari Respiratory Equipment Inc.
    • Recipharm AB
    • Verona Pharma plc
図表

List of Figures

  • Figure 1: Global: COPD and Asthma Devices Market: Major Drivers and Challenges
  • Figure 2: Global: COPD and Asthma Devices Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: COPD and Asthma Devices Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: COPD and Asthma Devices Market: Breakup by Product (in %), 2023
  • Figure 5: Global: COPD and Asthma Devices Market: Breakup by Indication (in %), 2023
  • Figure 6: Global: COPD and Asthma Devices Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: COPD and Asthma Devices Market: Breakup by Region (in %), 2023
  • Figure 8: Global: COPD and Asthma Devices (Inhalers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: COPD and Asthma Devices (Inhalers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: COPD and Asthma Devices (Nebulizers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: COPD and Asthma Devices (Nebulizers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: COPD and Asthma Devices (Asthma) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: COPD and Asthma Devices (Asthma) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: COPD and Asthma Devices (COPD) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: COPD and Asthma Devices (COPD) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: COPD and Asthma Devices (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: COPD and Asthma Devices (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: COPD and Asthma Devices (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: COPD and Asthma Devices (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: COPD and Asthma Devices (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: COPD and Asthma Devices (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: North America: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: North America: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: United States: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: United States: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Canada: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Canada: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Asia-Pacific: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Asia-Pacific: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: China: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: China: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Japan: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Japan: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: India: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: India: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: South Korea: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: South Korea: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Australia: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Australia: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Indonesia: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Indonesia: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Others: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Europe: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Europe: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Germany: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Germany: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: France: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: France: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: United Kingdom: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: United Kingdom: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Italy: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Italy: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Spain: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Spain: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Russia: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Russia: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Others: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Latin America: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Latin America: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Brazil: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Brazil: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Mexico: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Mexico: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Others: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Middle East and Africa: COPD and Asthma Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Middle East and Africa: COPD and Asthma Devices Market: Breakup by Country (in %), 2023
  • Figure 70: Middle East and Africa: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Global: COPD and Asthma Devices Industry: SWOT Analysis
  • Figure 72: Global: COPD and Asthma Devices Industry: Value Chain Analysis
  • Figure 73: Global: COPD and Asthma Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: COPD and Asthma Devices Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: COPD and Asthma Devices Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: COPD and Asthma Devices Market Forecast: Breakup by Indication (in Million US$), 2024-2032
  • Table 4: Global: COPD and Asthma Devices Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: COPD and Asthma Devices Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: COPD and Asthma Devices Market: Competitive Structure
  • Table 7: Global: COPD and Asthma Devices Market: Key Players
目次
Product Code: SR112024A6126

The global COPD and asthma devices market size reached US$ 45.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 69.5 Billion by 2032, exhibiting a growth rate (CAGR) of 4.6% during 2024-2032.

Chronic obstructive pulmonary disease (COPD) is an inflammatory disease that leads to obstructed airflow from the lungs. Its early symptoms include shortness of breath, wheezing, chest tightness, chronic cough with or without mucus, frequent cold, and throat soreness. On the other hand, asthma, also known as bronchial asthma, is a respiratory disorder that affects the airways in the lungs. Its symptoms are shortness of breath, chest tightness, trouble sleeping, and coughing or wheezing attacks. These respiratory diseases are treated using various devices that help deliver inhaled medication. COPD and asthma devices, also known as pulmonary drug delivery devices, are used as permanent treatment or rescue therapy for respiratory diseases. As a result, they are gaining immense traction across the globe.

COPD and Asthma Devices Market Trends:

The growing global geriatric population, which is highly susceptible to chronic respiratory disorders, represents one of the key factors positively influencing the market. In addition, rising occurrences of respiratory diseases caused due to the rising smoking of cigarettes are increasing the sales of COPD and asthma devices. Apart from this, the increasing expenditure on healthcare and continuous automation in the healthcare industry are contributing to the market growth. The widespread adoption of advanced medical solutions is offering lucrative growth opportunities to manufacturers across the globe. At present, healthcare practitioners and pulmonary diseases specialists are preferring a combination of a drug and a device on account of their fast and effective outcome. Furthermore, the expansion of chemical industries is resulting in the rising environmental pollution level and breathing problems, which, in turn, is driving the market. Additionally, the introduction of portable drug delivery devices is propelling the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global COPD and asthma devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, indication and distribution channel.

Breakup by Product:

Inhalers

Drug Powdered Inhalers (DPIs)

Metered Dose Inhalers (MDIs)

Soft Mist Inhalers

Nebulizers

Compressor Nebulizers

Ultrasonic Nebulizers

Mesh Nebulizers

Breakup by Indication:

Asthma

COPD

Breakup by Distribution Channel:

Retail Pharmacies

Hospitals

Online Pharmacies

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Adherium Limited, Aristopharma Ltd., AstraZeneca PLC, Baxter International Inc., Boehringer Ingelheim International GmbH, Cohero Health Inc., Koninklijke Philips N.V., Omron Corporation, Pari Respiratory Equipment Inc., Recipharm AB and Verona Pharma plc.

Key Questions Answered in This Report

  • 1. What was the size of the global COPD and asthma devices market in 2023?
  • 2. What is the expected growth rate of the global COPD and asthma devices market during 2024-2032?
  • 3. What are the key factors driving the global COPD and asthma devices market?
  • 4. What has been the impact of COVID-19 on the global COPD and asthma devices market?
  • 5. What is the breakup of the global COPD and asthma devices market based on the product?
  • 6. What is the breakup of the global COPD and asthma devices market based on the indication?
  • 7. What is the breakup of the global COPD and asthma devices market based on distribution channel?
  • 8. What are the key regions in the global COPD and asthma devices market?
  • 9. Who are the key players/companies in the global COPD and asthma devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global COPD and Asthma Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Inhalers
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Drug Powdered Inhalers (DPIs)
      • 6.1.2.2 Metered Dose Inhalers (MDIs)
      • 6.1.2.3 Soft Mist Inhalers
    • 6.1.3 Market Forecast
  • 6.2 Nebulizers
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Compressor Nebulizers
      • 6.2.2.2 Ultrasonic Nebulizers
      • 6.2.2.3 Mesh Nebulizers
    • 6.2.3 Market Forecast

7 Market Breakup by Indication

  • 7.1 Asthma
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 COPD
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Retail Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hospitals
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Adherium Limited
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Aristopharma Ltd.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 AstraZeneca PLC
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Baxter International Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Boehringer Ingelheim International GmbH
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Cohero Health Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Koninklijke Philips N.V.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Omron Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Pari Respiratory Equipment Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Recipharm AB
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Verona Pharma plc
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis